A phase II/III, randomized, double-blind, parallel-group, placebo-controlled, multicenter study to evaluate the safety and efficacy of rituximab in adults with primary progressive multiple sclerosis

Trial Profile

A phase II/III, randomized, double-blind, parallel-group, placebo-controlled, multicenter study to evaluate the safety and efficacy of rituximab in adults with primary progressive multiple sclerosis

Completed
Phase of Trial: Phase II/III

Latest Information Update: 08 Jan 2016

At a glance

  • Drugs Rituximab (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms OLYMPUS
  • Sponsors Genentech
  • Most Recent Events

    • 01 Oct 2009 Results published in Annals of Neurology.
    • 12 May 2009 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
    • 12 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top